Incidence of Cardiovascular Complications and Nephropathy in Patients with Type 2 Diabetes in a Primary Care Setting in Riyadh, Saudi Arabia

References

• Mathers CD , Loncar D , Samet J . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med . 2006;28(11):e442. doi:10.1371/journal.pmed.0030442
   Web of Science ®Google Scholar
• El Bcheraoui C , Basulaiman M , Tuffaha M , et al. Status of the diabetes epidemic in the Kingdom of Saudi Arabia, 2013. Int J Public Health . 2014;59(6):1011–1021. doi:10.1007/s00038-014-0612-4 25292457
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017 . Atlanta, GA: Division of Diabetes Translation, US Department of Health and Human Services; Vol. 20, 2017 7 17.
   Google Scholar
• Memish ZA , Jaber S , Mokdad AH , AlMazroa MA , Murray CJ , Al Rabeeah AA . Peer-reviewed: burden of disease, injuries, and risk factors in the Kingdom of Saudi Arabia, 1990–2010. Prev Chronic Dis . 2014;11(1):140176. doi:10.5888/pcd11.140176
   Web of Science ®Google Scholar
• Levin AS , Bilous RW , Coresh J . Chapter 1: definition and classification of CKD. Kidney Int Suppl . 2013;3(1):19–62.
   Google Scholar
• Alwakeel JS , Sulimani R , Al-Asaad H , et al. Diabetes complications in 1952 type 2 diabetes mellitus patients managed in a single institution in Saudi Arabia. Ann Saudi Med . 2008;28(4):260–266. doi:10.5144/0256-4947.2008.260 18596402
   PubMed Web of Science ®Google Scholar
• Ghandour R , Mikki N , Rmeileh NM , et al. Complications of type 2 diabetes mellitus in Ramallah and al-Bireh: the Palestinian diabetes complications and control study (PDCCS). PCDE . 2018;12:547–557.
   Google Scholar
• Adler AI , Stevens RJ , Manley SE , Bilous RW , Cull CA , Holman RR ; UKPDS Group. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int . 2003;63(1):225–232. doi:10.1046/j.1523-1755.2003.00712.x 12472787
   PubMed Web of Science ®Google Scholar
• Turner RC , Millns H , Neil HA , et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: united Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ . 1998;316(7134):823–828. doi:10.1136/bmj.316.7134.823 9549452
   PubMed Web of Science ®Google Scholar
• Al-Rubeaan K , Youssef AM , Subhani SN , et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi National Diabetes Registry-based study. PLoS One . 2014;9(2):e88956. doi:10.1371/journal.pone.0088956 24586457
   PubMed Web of Science ®Google Scholar
• Al-Wakeel JS , Hammad D , Al Suwaida A , Mitwalli AH , Memon NA , Sulimani F . Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl . 2009;20:77.19112222
   PubMedGoogle Scholar
• Bukhsh A , Khan TM , Nawaz MS , Ahmed HS , Chan KG , Goh BH . Association of diabetes knowledge with glycemic control and self-care practices among Pakistani people with type 2 diabetes mellitus. Diabetes Metab Syndr Obes . 2019;12:1409. doi:10.2147/DMSO.S209711 31616171
   PubMed Web of Science ®Google Scholar
• Afroz A , Zhang W , Loh AJ , Lee DX , Billah B . Macro-and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh. Diabetes Metab Syndr . 2019;13(5):2939–2946. doi:10.1016/j.dsx.2019.07.046 31425960
   PubMed Web of Science ®Google Scholar
• Arambewela MH , Somasundaram NP , Jayasekara HB , et al. Prevalence of chronic complications, their risk factors, and the cardiovascular risk factors among patients with type 2 diabetes attending the diabetic clinic at a Tertiary Care Hospital in Sri Lanka. J Diabetes Res . 2018;2018:2018. doi:10.1155/2018/4504287
   Web of Science ®Google Scholar
• Stratton IM , Adler AI , Neil HA , et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ . 2000;321(7258):405–412. doi:10.1136/bmj.321.7258.405 10938048
   PubMed Web of Science ®Google Scholar
• Prattichizzo F , de Candia P , De Nigris V , Nicolucci A , Ceriello A . Legacy effect of intensive glucose control on major adverse cardiovascular outcome: systematic review and meta-analyses of trials according to different scenarios. Metabolism . 2020;110:154308. doi:10.1016/j.metabol.2020.154308 32628943
   PubMed Web of Science ®Google Scholar
• Valensi P , Prévost G , Schnell O , Standl E , Ceriello A . Targets for blood glucose: what have the trials told us. Eur J Prev Cardiol . 2019;26(2_suppl):64–72. doi:10.1177/2047487319885456 31766916
   PubMed Web of Science ®Google Scholar
• Ruospo M , Saglimbene VM , Palmer SC , et al. Glucose targets for preventing diabetic kidney disease and its progression. Cochrane Database Syst Rev . 2017;(6).
   Web of Science ®Google Scholar
• Zoungas S , Arima H , Gerstein HC , et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol . 2017;5(6):431–437. doi:10.1016/S2213-8587(17)30104-3 28365411
   PubMed Web of Science ®Google Scholar
• Alsulaiman TA , Al-Ajmi HA , Al-Qahtani SM , et al. Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia. J Family Community Med . 2016;23(1):1. doi:10.4103/2230-8229.172221 26929722
   PubMedGoogle Scholar
• Abouammoh NA , Alshamrani MA . Knowledge about diabetes and glycemic control among diabetic patients in Saudi Arabia. J Diabetes Res . 2020;2020:1–6. doi:10.1155/2020/1239735
   Web of Science ®Google Scholar
• Alramadan MJ , Magliano DJ , Almigbal TH , et al. Glycaemic control for people with type 2 diabetes in Saudi Arabia–an urgent need for a review of management plan. BMC Endocr Disord . 2018;18(1):62. doi:10.1186/s12902-018-0292-9 30200959
   PubMed Web of Science ®Google Scholar
• Marso SP , Bain SC , Consoli A , Eliaschewitz FG , Jodar E , Leiter LA . SUSTAIN-6 Investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med . 2016;2016:375.
   Google Scholar
• Marso SP , Daniels GH , Brown-Frandsen K , et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med . 2016;375(4):311–322. doi:10.1056/NEJMoa1603827 27295427
   PubMed Web of Science ®Google Scholar
• Mann JF , Ørsted DD , Brown-Frandsen K , et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med . 2017;377(9):839–848. doi:10.1056/NEJMoa1616011 28854085
   PubMed Web of Science ®Google Scholar
• Zinman B , Wanner C , Lachin JM , et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med . 2015;373(22):2117–2128. doi:10.1056/NEJMoa1504720 26378978
   PubMed Web of Science ®Google Scholar